Page last updated: 2024-09-04

lonafarnib and Germinoblastoma

lonafarnib has been researched along with Germinoblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lowe, SW; Mavrakis, KJ; Mills, JR; Pelletier, J; Silva, RL; Tam, W; Teruya-Feldstein, J; Wendel, HG; Zhu, H	1
Groffen, J; Heisterkamp, N; Mishra, S; Zhang, B	1

Other Studies

2 other study(ies) available for lonafarnib and Germinoblastoma

Article	Year
Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes & development, 2008, Aug-15, Volume: 22, Issue:16 Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Doxorubicin; Eukaryotic Initiation Factor-4E; Farnesyltranstransferase; Female; Fibroblasts; Gene Dosage; Humans; Immunophenotyping; Immunosuppressive Agents; Lymphoma; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Neuropeptides; Phosphorylation; Piperidines; Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; PTEN Phosphohydrolase; Pyridines; Ras Homolog Enriched in Brain Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Suppressor Protein p53	2008
A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl. Leukemia, 2004, Volume: 18, Issue:1 Topics: Administration, Oral; Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Benzamides; Disease Models, Animal; Farnesyltranstransferase; Female; Fusion Proteins, bcr-abl; Imatinib Mesylate; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Nude; Mice, Transgenic; Piperazines; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Survival Rate; Tumor Cells, Cultured	2004

Article

Year

Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

Genes & development, 2008, Aug-15, Volume: 22, Issue:16

Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Doxorubicin; Eukaryotic Initiation Factor-4E; Farnesyltranstransferase; Female; Fibroblasts; Gene Dosage; Humans; Immunophenotyping; Immunosuppressive Agents; Lymphoma; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Neuropeptides; Phosphorylation; Piperidines; Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; PTEN Phosphohydrolase; Pyridines; Ras Homolog Enriched in Brain Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Suppressor Protein p53

2008

A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.

Leukemia, 2004, Volume: 18, Issue:1

Topics: Administration, Oral; Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Benzamides; Disease Models, Animal; Farnesyltranstransferase; Female; Fusion Proteins, bcr-abl; Imatinib Mesylate; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Nude; Mice, Transgenic; Piperazines; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Survival Rate; Tumor Cells, Cultured

2004